Arcadia Biosciences
RKDA
13 hedge funds and large institutions have $2.82M invested in Arcadia Biosciences in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
18% more funds holding
Funds holding: 11 → 13 (+2)
0.23% less ownership
Funds ownership: 0.41% → 0.18% (-0.23%)
72% less capital invested
Capital invested by funds: $10M → $2.82M (-$7.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.63M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$615K |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$342K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$168K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$24.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$4.14M |
| 2 |
Renaissance Technologies
New York
|
-$1.06M |
| 3 |
LRPA
L. Roy Papp & Associates
Phoenix,
Arizona
|
-$445K |
| 4 |
Squarepoint
New York
|
-$399K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$392K |
RKDA Hedge Fund Activity: Q2 2018 in Review
13 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2018, worth a combined $2.82M — down 72% from $10M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RKDA positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $1.63M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $4.14M sold.
- 13 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2018, up from 11 in Q1 2018.
- Funds reported $2.82M of Arcadia Biosciences stock for Q2 2018, down 72% quarter-over-quarter.
- 7 funds opened new Arcadia Biosciences positions in Q2 2018 and 5 closed out, a net change of +2 holders.
- The largest Arcadia Biosciences buyer in Q2 2018 was CVI Holdings, an estimated $1.63M added.
- The largest Arcadia Biosciences seller in Q2 2018 was Hudson Bay Capital Management, an estimated $4.14M sold.
Based on aggregated 13F filings for Q2 2018.